Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase)

被引：2

作者：

Boveda, Serge ^{[1
]}

Garcia, Rodrigue ^{[2
,3
]}

Defaye, Pascal ^{[4
]}

Piot, Olivier ^{[5
]}

Narayanan, Kumar ^{[6
,7
]}

Barra, Sergio ^{[8
,9
]}

Gras, Daniel ^{[10
]}

Providencia, Rui ^{[1
,11
]}

Algalarrondo, Vincent ^{[12
]}

Beganton, Frankie ^{[6
]}

Perier, Marie-Cecile ^{[6
]}

Jacob, Sophie ^{[13
]}

Bordachar, Pierre ^{[14
]}

Babuty, Dominique ^{[15
]}

Klug, Didier ^{[16
]}

Leclercq, Christophe ^{[17
]}

Fauchier, Laurent ^{[15
]}

Sadoul, Nicolas ^{[18
]}

Deharo, Jean-Claude ^{[19
]}

Marijon, Eloi ^{[6
,20
,21
]}

机构：

[1] Clin Pasteur, F-31076 Toulouse, France

[2] CHU Poitiers, F-86021 Poitiers, France

[3] Univ Poitiers, F-86073 Poitiers, France

[4] CHU Grenoble, F-38700 La Tronche, France

[5] Ctr Cardiol Nord, F-93200 St Denis, Reunion, France

[6] Paris Cardiovasc Res Ctr, INSERM, U970, F-75015 Paris, France

[7] Maxcure Hosp, Hyderabad 500081, Telangana, India

[8] Cambridge Univ Hlth Partners, Royal Papworth Hosp NHS Fdn Trust, Cambridge CB2 0AY, England

[9] Hosp Luz Arrabida, P-4400346 Vila Nova De Gaia, Portugal

[10] Hop Prive Confluent, Nantes, France

[11] Barts Hlth NHS Trust, Barts Heart Ctr, London EC1A 7BE, England

[12] Hop Bichat Claude Bernard, F-75018 Paris, France

[13] IRSN, F-92260 Fontenay Aux Roses, France

[14] CHU Haut Leveque, F-33600 Pessac, France

[15] CHU Trousseau, F-37170 Chambray Les Tours, France

[16] CHRU Lille, F-59000 Lille, France

[17] CHU Pontchaillou, F-35033 Rennes, France

[18] CHU Brabois, F-54500 Vandoeuvre Les Nancy, France

[19] Hop La Timone, F-13005 Marseille, France

[20] Hop Europeen Georges Pompidou, Unite Rythmol, 20-40 Rue Leblanc, F-75908 Paris 15, France

[21] Paris Descartes Univ, F-75006 Paris, France

来源：

ARCHIVES OF CARDIOVASCULAR DISEASES | 2019年 / 112卷 / 8-9期

关键词：

Implantable cardioverter defibrillator; Primary prevention; Sudden cardiac death; Complications; Epidemiology; OUTCOMES; RESYNCHRONIZATION; CARDIOMYOPATHY; MORTALITY; SOCIETY; BENEFIT;

D O I：

10.1016/j.acvd.2019.05.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review summarizes the main findings of the French multicentre DAI-PP pilot programme, and discusses the related clinical and research perspectives. This project included retrospectively (2002-2012 period) more than 5000 subjects with structural heart disease who received an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death, and were followed for a mean period of 3 years. The pilot phase of the DAI-PP programme has provided valuable information on several practical and clinically relevant aspects of primary prevention ICD implantation in the real-world population, which are summarized in this review. This pilot has led to a prospective evaluation that started in May 2018, assessing ICD therapy in primary and secondary prevention in patients with structural and electrical heart diseases, with remote monitoring follow-up using a dedicated platform. This should further enhance our understanding of sudden cardiac death, to eventually optimize the field of preventative actions. (C) 2019 Elsevier Masson SAS. All rights reserved.

引用

页码：523 / 531

页数：9

共 35 条

[1] Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation [J].

Algalarrondo, Vincent ;

Perault, Romain ;

Bories, Marie-Cecile ;

Narayanan, Kumar ;

Garcia, Rodrigue ;

Combes, Nicolas ;

Perier, Marie-Cecile ;

Defaye, Pascal ;

Sadoul, Nicolas ;

Gras, Daniel ;

Klug, Didier ;

Bordachar, Pierre ;

Fauchier, Laurent ;

Deharo, Jean-Claude ;

Leclercq, Christophe ;

Boveda, Serge ;

Marijon, Eloi ;

Babuty, Dominique .

ARCHIVES OF CARDIOVASCULAR DISEASES, 2018, 111 (12) :758-765

[2] Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death [J].

Amara, Nelly ;

Boveda, Serge ;

Defaye, Pascal ;

Klug, Didier ;

Treguer, Frederic ;

Amet, Denis ;

Perier, Marie-Cecile ;

Gras, Daniel ;

Algalarrondo, Vincent ;

Bouzeman, Abdeslam ;

Piot, Olivier ;

Deharo, Jean-Claude ;

Fauchier, Laurent ;

Babuty, Dominique ;

Bordachar, Pierre ;

Sadoul, Nicolas ;

Marijon, Eloi ;

Leclercq, Christophe .

EUROPACE, 2018, 20 (01) :65-72

[3]

Anantha Narayanan Mahesh, 2017, JACC Clin Electrophysiol, V3, P962, DOI 10.1016/j.jacep.2017.02.006

[4] Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention [J].

Ascoeta, Maria Soledad ;

Marijon, Eloi ;

Defaye, Pascal ;

Klug, Didier ;

Beganton, Frankie ;

Perier, Marie-Cecile ;

Gras, Daniel ;

Algalarrondo, Vincent ;

Deharo, Jean-Claude ;

Leclercq, Christophe ;

Fauchier, Laurent ;

Babuty, Dominique ;

Bordachar, Pierre ;

Sadoul, Nicolas ;

Boveda, Serge ;

Piot, Olivier .

HEART RHYTHM, 2016, 13 (05) :1045-1051

[5] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].

Bardy, GH ;

Lee, KL ;

Mark, DB ;

Poole, JE ;

Packer, DL ;

Boineau, R ;

Domanski, M ;

Troutman, C ;

Anderson, J ;

Johnson, G ;

McNulty, SE ;

Clapp-Channing, N ;

Davidson-Ray, LD ;

Fraulo, ES ;

Fishbein, DP ;

Luceri, RM ;

Ip, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237

[6] Very long-term survival and late sudden cardiac death in cardiac resynchronization therapy patients [J].

Barra, Sergio ;

Duehmke, Rudolf ;

Providencia, Rui ;

Narayanan, Kumar ;

Reitan, Christian ;

Roubicek, Tomas ;

Polasek, Rostislav ;

Chow, Antony ;

Defaye, Pascal ;

Fauchier, Laurent ;

Piot, Olivier ;

Deharo, Jean-Claude ;

Sadoul, Nicolas ;

Klug, Didier ;

Garcia, Rodrigue ;

Dockrill, Seth ;

Virdee, Munmohan ;

Pettit, Stephen ;

Agarwal, Sharad ;

Borgquist, Rasmus ;

Marijon, Eloi ;

Boveda, Serge .

EUROPEAN HEART JOURNAL, 2019, 40 (26) :2121-2127

[7] Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator? [J].

Barra, Sergio ;

Providencia, Rui ;

Boveda, Serge ;

Narayanan, Kumar ;

Virdee, Munmohan ;

Marijon, Eloi ;

Agarwal, Sharad .

EUROPACE, 2018, 20 (06) :897-901

[8] The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities [J].

Barra, Sergio ;

Providencia, Rui ;

Agarwal, Sharad ;

Marijon, Eloi ;

Boveda, Serge .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) :2096-2097

[9] Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure [J].

Barra, Sergio ;

Providencia, Rui ;

Duehmke, Rudolf ;

Boveda, Serge ;

Marijon, Eloi ;

Reitan, Christian ;

Borgquist, Rasmus ;

Klug, Didier ;

Defaye, Pascal ;

Sadoul, Nicolas ;

Deharo, Jean-Claude ;

Sadien, Iannish ;

Patel, Kiran ;

Looi, Khang-Li ;

Begley, David ;

Chow, Anthony W. ;

Le Heuzey, Jean-Yves ;

Agarwal, Sharad .

HEART, 2017, 103 (10) :753-760

[10] Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate [J].

Barra, Sergio ;

Boveda, Serge ;

Providencia, Rui ;

Sadoul, Nicolas ;

Duehmke, Rudolf ;

Reitan, Christian ;

Borgquist, Rasmus ;

Narayanan, Kumar ;

Hidden-Lucet, Francoise ;

Klug, Didier ;

Defaye, Pascal ;

Gras, Daniel ;

Anselme, Frederic ;

Leclercq, Christophe ;

Hermida, Jean-Sebastien ;

Deharo, Jean-Claude ;

Looi, Khang-Li ;

Chow, Anthony W. ;

Virdee, Munmohan ;

Fynn, Simon ;

Le Heuzey, Jean-Yves ;

Marijon, Eloi ;

Agarwal, Sharad .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (13) :1669-1678

← 1 2 3 4 →